AzTrials
AzTrials

Clinical trials: Contraceptive Implant

What
Where
Study
Who can join
Dates
Clear all

31 studies

  • Contraception

    LARC Forward Contraceptive Counseling at MHCC

    • Terminated
    • Age: 17 to 30 years
    • Phase 4
    • Results posted

    This prospective randomized controlled study will evaluate if Long Acting Reversible Contraceptive (LARC) forward counseling in combination with same-day LARC placement increases overall LARC uptake within a community college…

    Trial name
    NCT02735551
    Testing
    Long Acting Reversible Contraception (LARC), Referral for Long Acting Reversible Contraception (LARC), Prescription for Short-Acting Hormonal Contraception
    Where
    United States
    Volunteers
    3 people, healthy volunteers welcome
    Sponsor
    Oregon Health and Science University
    Can I take part? NCT02735551

  • Contraception

    Postplacental Intrauterine Device Insertion: A Mixed Methods Assessment of Women's Experience

    • Completed
    • Age: 18 years and older
    • Observational study
    • Surgery or procedure
    • Results posted

    The primary objective of this mixed methods pilot study is to understand women's experiences with postplacental intrauterine device (IUD) insertion through postpartum semi-structured interviews.

    Trial name
    PIPPI (NCT02312726)
    Testing
    Postplacental IUD insertion
    Where
    United States
    Volunteers
    135 people, healthy volunteers welcome
    Sponsor
    University of New Mexico
    Can I take part? PIPPI

  • Contraception

    Nitrous Oxide for Pain Management of Intrauterine Device (IUD) Insertion

    • Completed
    • Age: 12 years and older
    • Surgery or procedure
    • Results posted

    The purpose of this study is to determine whether Nitrous Oxide is effective in achieving pain control and satisfaction among nulliparous women getting the intrauterine device (IUD).

    Trial name
    NIUD (NCT02391714)
    Testing
    IUD insertion, Povidone-Iodine, Chlorhexidine
    Where
    United States
    Volunteers
    80 people, healthy volunteers welcome
    Sponsor
    University of New Mexico
    Can I take part? NIUD

  • Contraception

    The Effect of Isotretinoin on the Etonogestrel Contraceptive Implant

    • Completed
    • Age: 18 to 45 years
    • Observational study
    • Results posted

    This exploratory study will fill a knowledge gap regarding the pharmacokinetic effects of isotretinoin on the etonogestrel (ENG) contraceptive implant.

    Trial name
    NCT02967055
    Where
    United States
    Volunteers
    9 people, healthy volunteers welcome
    Sponsor
    University of Colorado, Denver
    Can I take part? NCT02967055

  • Menstruation Disturbances

    Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users

    • Completed
    • Age: 15 to 45 years
    • Phase 4
    • Results posted

    The purpose of this study is to study whether a drug called tamoxifen can reduce vaginal bleeding in women who are using the Etonogestrel contraceptive implant.

    Trial name
    NCT02070692
    Testing
    Tamoxifen
    Where
    United States
    Volunteers
    56 people
    Sponsor
    Oregon Health and Science University
    Can I take part? NCT02070692

  • Contraception Behavior

    Premature Discontinuation of Contraceptive Implants

    • Completed
    • Age: 14 to 23 years
    • Phase 4
    • Pill or oral medicine
    • Results posted

    To compare rates of etonogestrel implant discontinuation in implant initiators who are given advance provision of combined oral contraceptive pills (COCs) and a bleeding rescue regimen (COCR intervention) to participants given…

    Trial name
    NCT04828824
    Testing
    Ethinyl Estradiol / Norgestimate Oral Tablet
    Where
    United States
    Volunteers
    600 people, healthy volunteers welcome
    Sponsor
    University of Colorado, Denver
    Can I take part? NCT04828824

  • Contraception, Breastfeeding

    Immediate Postpartum Contraceptive Implant Placement and Breastfeeding Success in Women at Risk for Low Milk Supply: A Non-inferiority Trial

    • Completed
    • Age: 17 to 45 years
    • Medical device
    • Results posted

    The investigators goal is to measure the impact of timing of postpartum contraceptive implant insertion on breastfeeding success and duration and to explore women's experiences with and attitudes towards contraceptive and…

    Conditions
    Contraception, Breastfeeding, Postpartum Contraception
    Trial name
    NCT02866279
    Testing
    Etonogestrel Contraceptive Implant
    Where
    United States
    Volunteers
    155 people, healthy volunteers welcome
    Sponsor
    Montefiore Medical Center
    Can I take part? NCT02866279

  • Contraceptive Usage

    Immediate Versus Delayed Insertion of Implanon in Postpartum Adolescents

    • Completed
    • Age: 15 to 21 years
    • Phase 3
    • Results posted

    The specific aim of this study is to evaluate whether insertion of a long-acting contraceptive implant in postpartum adolescents prior to hospital discharge increases use of this highly effective contraception during the first…

    Trial name
    Implanon (NCT03585504)
    Testing
    Etonogestrel contraceptive implant
    Where
    United States
    Volunteers
    81 people, healthy volunteers welcome
    Sponsor
    Medical University of South Carolina
    Can I take part? Implanon

  • Contraceptive Usage

    'Levonorgestrel IUD Insertion After D&E Procedure

    • Completed
    • Age: 18 years and older
    • Phase 4
    • Results posted

    This study is a randomized controlled trial of insertion of the levonorgestrel-releasing intrauterine device (LNG-IUD) immediately following dilation \& evacuation (D\&E) compared to delayed insertion 3-6 weeks post-D\&E.

    Trial name
    ILIAD (NCT00475228)
    Testing
    Levonorgestrel IUD
    Where
    United States
    Volunteers
    93 people, healthy volunteers welcome
    Sponsor
    University of Pittsburgh
    Can I take part? ILIAD

  • Bleeding, Implants

    Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users

    • Completed
    • Age: 15 to 45 years
    • Phase 4
    • Results posted

    The investigators plan to study the effects of curcumin, the active ingredient in the spice turmeric, on the irregular bleeding experienced by women who use the contraceptive implant.

    Conditions
    Bleeding, Implants, Breakthrough Bleeding
    Trial name
    NCT04205929
    Testing
    Curcumin
    Where
    United States
    Volunteers
    58 people, healthy volunteers welcome
    Sponsor
    Oregon Health and Science University
    Can I take part? NCT04205929

  • Contraception, Unintended Pregnancy

    Innovative Model of Patient-Centered ConTraception

    • Completed
    • Age: 14 to 45 years
    • Medical device
    • Lifestyle or therapy programme
    • Results posted

    This study is testing models of contraceptive care that were developed as part of the Contraceptive CHOICE Project. CHOICE is a prospective cohort study of 9,256 women designed to: 1) promote the use of long-acting reversible…

    Trial name
    IMPACCT (NCT02364037)
    Testing
    CHOICE Project Structured Contraceptive Counseling, Contraceptive Education Session, Cost Support for IUDs and implants
    Where
    3 sites in United States
    Volunteers
    1,008 people, healthy volunteers welcome
    Sponsor
    Washington University School of Medicine
    Can I take part? IMPACCT

  • Bleeding, Implants

    Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users

    • Completed
    • Age: 15 to 45 years
    • Phase 4
    • Results posted

    The etonogestrel (ENG) subdermal contraceptive implant (ENG implant) is a highly effective method of preventing pregnancy, but it has bleeding side effects that make it unappealing for many women.

    Conditions
    Bleeding, Implants, Breakthrough Bleeding
    Trial name
    Tamoxifen/BTB (NCT02903121)
    Testing
    Tamoxifen, Tamoxifen (open label)
    Where
    United States
    Volunteers
    109 people, healthy volunteers welcome
    Sponsor
    Oregon Health and Science University
    Can I take part? Tamoxifen/BTB

  • Continuation Rate of Contraceptive Implant

    Immediate vs. Delayed Postpartum Etonogestrel Implant

    • Completed
    • Age: 12 to 40 years
    • Phase 4
    • Results posted

    The investigators are examining if there is a difference in continuation rates of the etonogestrel contraceptive implant between women who have the device placed immediately after delivery, before leaving the hospital, and women…

    Trial name
    NCT01767285
    Testing
    Etonogestrel implant
    Where
    United States
    Volunteers
    60 people, healthy volunteers welcome
    Sponsor
    Duke University
    Can I take part? NCT01767285

  • Etonogestrel Contraceptive Implant, Bothersome Bleeding

    Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive Implant

    • Completed
    • Age: All ages
    • Results posted

    The overall objective of this study is to confirm that oral progesterone is an effective way to manage bothersome bleeding; thus increasing the rate of continuation of the etonogestrel contraceptive implant in adolescents.

    Trial name
    NCT02353247
    Testing
    Norethindrone acetate
    Where
    United States
    Volunteers
    88 people
    Sponsor
    Norton Healthcare
    Can I take part? NCT02353247

  • Contraception, Malposition of Intrauterine Contraceptive Device

    LNG-IUS at 2 Weeks Postpartum

    • Completed
    • Age: 18 to 45 years
    • Phase 4
    • Results posted

    This is a study of 50 postpartum women interested in having the Mirena® LNG-IUS placed for contraception. The Mirena® is an FDA approved intrauterine contraceptive device that provides contraception for 5 years with excellent…

    Trial name
    LNG-IUS (NCT02121067)
    Testing
    Levonorgestrel Intrauterine System (LNG-IUS)
    Where
    United States
    Volunteers
    50 people, healthy volunteers welcome
    Sponsor
    University of North Carolina, Chapel Hill
    Can I take part? LNG-IUS

  • Contraception

    Nexplanon and Combined Oral Contraceptive (COC) Combined Use Study

    • Completed
    • Age: 16 to 35 years
    • Phase 4
    • Results posted

    Women currently using or starting a combined oral contraceptive will be offered study enrollment. Study subjects will have a Nexplanon placed and followed for 6 months to evaluate if they continue the COC, continue the implant…

    Trial name
    NexTOC (NCT02852265)
    Testing
    Etonogestrel contraceptive implant
    Where
    United States
    Volunteers
    20 people, healthy volunteers welcome
    Sponsor
    University of California, Davis
    Can I take part? NexTOC

  • Contraception

    Same Day Oral EC and Implant Initiation

    • Completed
    • Age: 18 to 35 years
    • Observational study
    • Pill or oral medicine
    • Medical device
    • Results posted

    This is a study for clients presenting for emergency contraception (EC). EC is used to prevent pregnancy after unprotected intercourse. Clients presenting for EC may be offered either the copper or hormonal IUD or oral EC.

    Trial name
    NCT04678817
    Testing
    Etonogestrel contraceptive implant with oral levonorgestrel, Levonorgestrel intrauterine device, Copper T380A intrauterine device
    Where
    2 sites in United States
    Volunteers
    306 people
    Sponsor
    University of Utah
    Can I take part? NCT04678817

  • Contraception

    Breastfeeding Etonogestrel Implant Study

    • Completed
    • Age: 13 years and older
    • Phase 4
    • Medical device
    • Results posted

    The investigators are studying the effect of placing the etonogestrel implant (Nexplanon) in the first 24 hours after birth on breastfeeding.

    Trial name
    LACTO-Rod (NCT03978598)
    Testing
    Etonogestrel, Nexplanon
    Where
    2 sites in United States
    Volunteers
    150 people, healthy volunteers welcome
    Sponsor
    University of New Mexico
    Can I take part? LACTO-Rod

  • Postpartum Contraception, Family Planning

    Labor and Delivery Implant Insertion: A Randomized Controlled Trial

    • Completed
    • Age: All ages
    • Phase 3
    • Results posted

    A barrier to initiating progestin contraceptives in the early postpartum period is the concern of interference with breastfeeding, specifically lactogenesis.

    Trial name
    LADII (NCT02866643)
    Testing
    Etonogestrel-Immediate, Etonogestrel-Delayed
    Where
    United States
    Volunteers
    95 people, healthy volunteers welcome
    Sponsor
    Stanford University
    Can I take part? LADII

  • Bleeding, Contraceptive Device; Complications

    Tranexamic Acid to Reduce Contraceptive-related Bleeding Side Effects

    • Completed
    • Age: 15 to 45 years
    • Phase 4
    • Results posted

    This randomized double blinded trial seeks to determine whether tranexamic acid (TXA) is an efficacious treatment for contraceptive induced menstrual changes (CIMC) including irregular, bothersome bleeding caused by the…

    Trial name
    NCT06000423
    Testing
    Tranexamic acid
    Where
    United States
    Volunteers
    65 people
    Sponsor
    Oregon Health and Science University
    Can I take part? NCT06000423

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in